Shanghai\u2019s healthcare security administration has announced a comprehensive set of measures aimed at enhancing community healthcare service capabilities. These initiatives include an appropriate increase in the outpatient and emergency clinic reimbursement ratio in primary medical institutions, aligning with the city’s commitment to improving access to healthcare services for its residents.<\/p>\n\n\n\n
Reimbursement Ratios and Drug Policies<\/strong> Outpatient Coordinated Services and Reimbursement Expansion<\/strong>
The National Reimbursement Drug List (NRDL) Category B drugs used in primary medical institutions will now be reimbursed in a manner similar to Category A drugs. This change is expected to ease the financial burden on patients seeking treatment in community healthcare settings. Volume-based procurement (VBP) drugs will continue to follow existing payment policies, ensuring a consistent approach to drug reimbursement.<\/p>\n\n\n\n
As of July 1, 2023, NRDL designated pharmacies have begun providing outpatient coordinated services. Insured individuals who purchase NRDL drugs from these pharmacies with electronic prescriptions from community health service centers will be included in the outpatient reimbursement scope. This move is designed to expand the channels for patient dispensing and ensure that patients receive the same level of outpatient treatment as they would at prescribing medical institutions.<\/p>\n\n\n\n